OSSIO vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
OSSIO is an orthopedic medical device company offering biocomposite fixation implants that resorb and are replaced by natural bone; OSSIOfiber technology avoids metal implant removal surgeries; raised $72M+ in total funding;
About
OSSIO is a medical device company founded in 2015 and headquartered in Andover, Massachusetts, that develops biocomposite orthopedic fixation implants as an alternative to traditional metal hardware. The company's proprietary OSSIOfiber technology platform combines a bioabsorbable polymer matrix reinforced with mineral fibers to create implants that are strong enough to stabilize bone during healing, yet gradually resorb and are replaced by the patient's own natural bone tissue over time. This eliminates the need for a second surgery to remove metal hardware — a common procedure with titanium screws and plates — reducing total patient burden and healthcare costs. OSSIOfiber implants are FDA-cleared for use in the foot, ankle, and hand.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.